<DOC>
	<DOCNO>NCT02605148</DOCNO>
	<brief_summary>To evaluate effect Gluten Free Diet ( GFD ) beta-cell function glucose metabolism subject one several islet autoantibody without dysglycemia baseline . Additionally , subject give treatment Vitamin D , omega fatty acid probiotic . Subjects randomize GFD normal diet 18 month . Beta cell function evaluate baseline , follow-up glucose tolerance test .</brief_summary>
	<brief_title>TEFA Family Prevention : Glutenfree Diet Preserve Beta-cell Function</brief_title>
	<detailed_description>The design randomize control study determine safety effect gluten free diet 18 month beta-cell function glucose metabolism . Lead-in nonstop supplement cocktail include vitamin D , omega fatty acid probiotic use equalize difference reduce know confounders . All study subject meet dietician obtain 3-day diet record receive instruction healthy normal diet GFD . Subjects ( n=60 ) 2-49.99 year age positive one several islet autoantibody recruit . Subjects one islet autoantibody do one several oral glucose tolerance test ( OGTT ) prior baseline visit . One islet autoantibody positive subject eligible dysglycemia . All subject randomize base baseline intravenous glucose tolerance test ( IvGTT ) OGTT subject without dysglycemia baseline . Beta-cell function glucose metabolism ( alternate IvGTT OGTT ) assess baseline 6 , 12 , 18 month treatment 6 month wash normal healthy diet . Adverse event safety Adverse event obtain visit study , monitor . It expect subject one several islet autoantibody show loss compare baseline beta-cell function glucose control . GFD expect reduce loss subject healthy diet .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>1 . Subjects two ( 2 ) 49,99 year age . 2 . At least one type 1 diabetesassociated autoantibody ( glutamic acid ( GADA ) , insulin ( IAA ) , insulinomaassociated protein 2 ( IA2A ) zinktransporter 8 ( ZnT8R/W/QA ) subject impaired glucose metabolism OR least two type 1 diabetesassociated autoantibody , regardless normal impaired glucose metabolism . 3 . Written inform consent research subject . If child , also child 's parent legal acceptable representative ( ) accord local regulation . 1 . Ongoing treatment immunosuppressant therapy ( topical inhale steroid accept ) . 2 . Diabetes . 3 . Treatment oral inject antidiabetic medication . 4 . Significantly abnormal hematology result screen . 5 . Participation clinical trial new chemical entity within previous 3 month . 6 . History hypercalcemia . 7 . Presence associate serious disease condition . 8 . Diabetesprotective HLADQ6allele .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Islet autoimmunity</keyword>
	<keyword>gluten free diet</keyword>
	<keyword>prediabetes</keyword>
	<keyword>prevention</keyword>
	<keyword>type 1 diabetes</keyword>
	<keyword>glucose tolerance test</keyword>
</DOC>